SummaryObesity increases the incidence of hepatocellular carcinoma (HCC) development in part through the activation of obesity-associated proinflammatory signaling. Here, we show that in lean mice, abrogation of IL-6Rα signaling protects against diethylnitrosamine (DEN)-induced HCC development. HCC protection occurs via Mcl-1 destabilization, thus promoting hepatocyte apoptosis. IL-6 regulates Mcl-1 stability via the inhibition of PP-1α expression, promoting GSK-3β inactivation. In addition, IL-6 suppresses expression of the Mcl-1 E3 ligase (Mule). Consequently, IL-6Rα deficiency activates PP-1α and Mule expression, resulting in increased Mcl-1 turnover and protection against HCC development. In contrast, in obesity, inhibition of PP-1α and...
SummaryObesity can result in insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (...
Obesity is a major driver of cancer, especially hepatocellular carcinoma (HCC). The prevailing view ...
Aims/hypothesis The role of IL-6 in the development of obesity and hepatic insulin resistance is unc...
SummaryObesity increases the incidence of hepatocellular carcinoma (HCC) development in part through...
Obesity increases the incidence of hepatocellular carcinoma (HCC) development in part through the ac...
There is growing evidence that obesity increases the risk of hepatocellular carcinoma (HCC). In a re...
SummaryEpidemiological studies indicate that overweight and obesity are associated with increased ca...
Obesity promotes the development of numerous cancers, such as liver and colorectal cancers, which is...
SummaryThe contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains cont...
Objective: The current obesity pandemic represents a major health burden, given that it predisposes ...
Objective: The current obesity pandemic represents a major health burden, given that it predisposes ...
Obesity can result in insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH) a...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
Although type 2 diabetes (T2D) is an established risk factor for hepatocellular carcinoma (HCC), the...
SummaryObesity can result in insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (...
Obesity is a major driver of cancer, especially hepatocellular carcinoma (HCC). The prevailing view ...
Aims/hypothesis The role of IL-6 in the development of obesity and hepatic insulin resistance is unc...
SummaryObesity increases the incidence of hepatocellular carcinoma (HCC) development in part through...
Obesity increases the incidence of hepatocellular carcinoma (HCC) development in part through the ac...
There is growing evidence that obesity increases the risk of hepatocellular carcinoma (HCC). In a re...
SummaryEpidemiological studies indicate that overweight and obesity are associated with increased ca...
Obesity promotes the development of numerous cancers, such as liver and colorectal cancers, which is...
SummaryThe contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains cont...
Objective: The current obesity pandemic represents a major health burden, given that it predisposes ...
Objective: The current obesity pandemic represents a major health burden, given that it predisposes ...
Obesity can result in insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH) a...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
The contribution of interleukin (IL)-6 signaling in obesity-induced inflammation remains controversi...
Although type 2 diabetes (T2D) is an established risk factor for hepatocellular carcinoma (HCC), the...
SummaryObesity can result in insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (...
Obesity is a major driver of cancer, especially hepatocellular carcinoma (HCC). The prevailing view ...
Aims/hypothesis The role of IL-6 in the development of obesity and hepatic insulin resistance is unc...